Company Description
IR Biosciences Holdings, Inc.. The Group's principal activity is to engage in the research and development of applications utilizing modified substance P, a naturally occurring immunomodulator. Derived from homeostatic substance P, the Group has ...
Breaking News
Forbes.com - August 24, 2008 12:29 PM
IR BioSciences Holdings, Inc., a development-stage biotechnology company focused on the research, development and licensing of Homspera(R), announced today that it has closed a $5 million round of financing with certain funds for which Brencourt ...
